Skip to content

A Trial Comparing Effectiveness of Dextrose Prolotherapy Versus Corticosteroids for Managing Pain in Moderate Knee Osteoarthritis

Comparative Efficacy of Dextrose Prolotherapy and Intra Articular Corticosteroids in Grade II Knee Osteoarthritis:A Randomized Controlled Trial - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100577
Enrollment
126
Registered
2026-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dextrose Prolotherapy: Participants will be positioned supine with the target knee flexed 10 15 and prepared under strict aseptic precautions using povidone-iodine and alcohol.Ultrasou

Sponsors

Nil Ratan Sircar Medical College and Hospital Kolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with primary knee osteoarthritis fulfulling ACR criteria. 2.Radiologically confirmed Kellgren Lawrence Grade II knee Osteoarthritis. 3.VAS pain score more than or equal to 6 in past 2 weeks. 4.Willing and able to provide informed consent and comply with study follow up.

Exclusion criteria

Exclusion criteria: 1.Intra-articular injection in any joint within the past 6 months. 2.Use of NSAIDs, analgesics, or slow-acting OA drugs within the restricted time frame. 3.History of knee surgery or arthroscopic procedure in the last 1 year. 4.Secondary or inflammatory arthritis, generalized OA, or coexisting hip/foot OA or back pain. 5.Ligament or meniscal injury, tense effusion, or cutaneous lesions over the knee. 6.BMI more than 35 7.Haemoglobin less than 10 g/dL. 8.Bleeding disorders, or anticoagulant therapy. 9.Presence of active infection, immunosuppression, neoplasm, or systemic illness (e.g., uncontrolled diabetes, thyroid disease). 10.Presence of nociplastic pain

Design outcomes

Primary

MeasureTime frame
Pain reduction measured by Visual Analogue Scale (VAS)Timepoint: Baeline 4 weeks 12 weeks

Secondary

MeasureTime frame
Functional outcome assessed by KOOS (Knee injury and Osteoarthritis Outcome Score). Duration of effect. Adverse events,if any. Timepoint: Baseline 4 weeks 12 weeks

Countries

India

Contacts

Public ContactPartha Pratim Das

NRS Medical College

drppdaspmr74@gmail.com9433943719

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026